Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS

Terminated

Conditions: Multiple Sclerosis

Interventions: Drug: Tecfidera

First Posted Date: 2014-08-18

Last Posted Date: 2016-09-05

Lead Sponsor: Yale University

Target Recruit Count: 7

Registration Number: NCT02218879

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

LATCH: Lactation Advice Thru Texting Can Help

Not Applicable

Completed

Conditions: Breastfeeding Support

Interventions: Behavioral: LATCH Intervention

First Posted Date: 2014-08-12

Last Posted Date: 2017-05-01

Lead Sponsor: Yale University

Target Recruit Count: 249

Registration Number: NCT02214849

Locations: 🇺🇸
Yale School of Public Health, New Haven, Connecticut, United States

Neurofeedback for Obsessive-Compulsive Disorder (OCD)

Not Applicable

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Behavioral: control feedback
Behavioral: neurofeedback

First Posted Date: 2014-08-01

Last Posted Date: 2022-02-11

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT02206945

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Active Surveillance of the Small Renal Mass

Completed

Conditions: Small Renal Mass, Kidney Cancer

First Posted Date: 2014-07-30

Last Posted Date: 2021-03-01

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT02204800

Locations: 🇺🇸
Yale New Haven Hospital Smilow Cancer Center, New Haven, Connecticut, United States

Tofacitnib for the Treatment of Alopecia Areata and Variants

Phase 2

Completed

Conditions: Alopecia Universalis (AU)
Alopecia Areata (AA)
Alopecia Totalis (AT)

Interventions: Drug: Tofacitinib Administration

First Posted Date: 2014-07-22

Last Posted Date: 2017-04-04

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT02197455

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.

Not Applicable

Completed

Conditions: Insulin Resistance

Interventions: Other: one bout of 45 minutes exercise

First Posted Date: 2014-07-21

Last Posted Date: 2024-08-15

Lead Sponsor: Yale University

Target Recruit Count: 41

Registration Number: NCT02196051

Locations: 🇺🇸
YCCI/YNNH Hospital Research Unit, New Haven, Connecticut, United States

Comparison of Nasal Steroids After FESS in CRSwNP

Not Applicable

Completed

Conditions: Sinusitis
Nasal Polyps

Interventions: Drug: fluticasone nasal spray
Drug: Budesonide head upright
Drug: Budesonide head forward

First Posted Date: 2014-07-18

Last Posted Date: 2018-02-08

Lead Sponsor: Yale University

Target Recruit Count: 32

Registration Number: NCT02194062

Locations: 🇺🇸
Yale Physicians Bldg, New Haven, Connecticut, United States
🇺🇸
Yale ENT Stratford, Stratford, Connecticut, United States

The Effects of Minocycline in Humans

Phase 1

Completed

Conditions: Memory Impairment

Interventions: Drug: Sugar pill
Drug: Minocycline

First Posted Date: 2014-07-17

Last Posted Date: 2019-09-19

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT02193269

Locations: 🇺🇸
Veteran Affairs Hospital, West Haven, Connecticut, United States

Reversal of Lipid-Induced Insulin Resistance

Not Applicable

Recruiting

Conditions: Insulin Resistance
NAFLD

Interventions: Behavioral: Caloric Restriction

First Posted Date: 2014-07-17

Last Posted Date: 2025-05-16

Lead Sponsor: Yale University

Target Recruit Count: 250

Registration Number: NCT02193295

Locations: 🇺🇸
Yale Center for Clinical Investigation HRU, New Haven, Connecticut, United States
🇺🇸
Magnetic Resonance Research Center (MRRC), New Haven, Connecticut, United States

Varenicline + Prazosin for Heavy Drinking Smokers

Early Phase 1

Completed

Conditions: Alcohol Use Disorders
Cigarette Smoking

Interventions: Drug: Varenicline
Drug: Placebo
Drug: Prazosin

First Posted Date: 2014-07-17

Last Posted Date: 2020-03-12

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT02193256

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy